CAPLIN POINT LABORATORIES
Back to Income Statement
|
CAPLIN POINT LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,187 Cr | ₹1,937 Cr | ₹1,694 Cr | ₹1,467 Cr | ₹1,269 Cr |
What is the latest Revenue of CAPLIN POINT LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,187 Cr |
| Mar2025 | ₹1,937 Cr |
| Mar2024 | ₹1,694 Cr |
| Mar2023 | ₹1,467 Cr |
| Mar2022 | ₹1,269 Cr |
How is Revenue of CAPLIN POINT LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,187 Cr | 12.89 | |
| Mar2025 | ₹1,937 Cr | 14.37 | |
| Mar2024 | ₹1,694 Cr | 15.50 | |
| Mar2023 | ₹1,467 Cr | 15.54 | |
| Mar2022 | ₹1,269 Cr | - | |
Compare Revenue of peers of CAPLIN POINT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CAPLIN POINT LABORATORIES | ₹18,098.3 Cr | 1.9% | -10.2% | 19.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 1.9% |
-10.2% |
19.2% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses